Michael Hall, MD, MS, CGAF presented his abstract titled “Modeling Uptake of Aspirin (ASA) and NSAIDs in Lynch Syndrome (LS) to Elucidate Barriers to Chemoprevention of Hereditary Cancers” at the 2024 CGA-IGC Annual Meeting today, November 15, 2024.
This work was also published simultaneously in the American Society of Clinical Oncology (ASCO)’s JCO Precision Oncology. You can read the full publication HERE